MENU
+Compare
EDSA
Stock ticker: NASDAQ
AS OF
Jul 21, 11:28 AM (EDT)
Price
$2.41
Change
+$0.01 (+0.42%)
Capitalization
16.85M

EDSA Edesa Biotech Forecast, Technical & Fundamental Analysis

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases... Show more

EDSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EDSA with price predictions
Jul 18, 2025

EDSA in downward trend: price may decline as a result of having broken its higher Bollinger Band on July 16, 2025

EDSA broke above its upper Bollinger Band on July 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 31 similar instances where the stock broke above the upper band. In of the 31 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDSA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on EDSA as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EDSA just turned positive on June 12, 2025. Looking at past instances where EDSA's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

EDSA moved above its 50-day moving average on July 09, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for EDSA crossed bullishly above the 50-day moving average on July 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EDSA advanced for three days, in of 228 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 84 cases where EDSA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EDSA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.653) is normal, around the industry mean (18.143). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). EDSA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (270.975).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EDSA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
EDSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EDSA is expected to report earnings to fall 47.77% to -15 cents per share on December 13

Edesa Biotech EDSA Stock Earnings Reports
Q3'23
Est.
$-0.16
Q1'25
Beat
by $0.08
Q2'23
Beat
by $0.06
Q1'23
Est.
$-0.12
Q4'22
Beat
by $0.05
The last earnings report on May 14 showed earnings per share of -30 cents, beating the estimate of -37 cents. With 13.15K shares outstanding, the current market capitalization sits at 16.85M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Spy Court
Phone
+1 289 800-9600
Employees
16
Web
https://www.edesabiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NUVB2.300.06
+2.68%
Nuvation Bio
CMT16.850.06
+0.36%
Core Molding Technologies
NVR7422.83-15.42
-0.21%
NVR
CARM0.39N/A
-0.78%
Carisma Therapeutics
NEOG4.74-0.12
-2.47%
Neogen Corp

EDSA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EDSA has been loosely correlated with YECO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if EDSA jumps, then YECO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDSA
1D Price
Change %
EDSA100%
+1.27%
YECO - EDSA
36%
Loosely correlated
N/A
DOMH - EDSA
36%
Loosely correlated
-4.01%
MBRX - EDSA
34%
Loosely correlated
-4.02%
ENTA - EDSA
33%
Loosely correlated
+4.29%
ETNB - EDSA
30%
Poorly correlated
-1.50%
More